Day: January 26, 2021
Saga Furs Oyj bokslutskommuniké 26.1.2021 kl 15.55Coronapandemins negativa inverkan på Saga Furs Oyj:s förmedlingsförsäljning minskade under den andra halvårsperioden – räkenskapsperiodens resultat dock klart förlustbringandeDetta är ett sammandrag av den bokslutskommuniké som Saga Furs Oyj har publicerat. Bokslutskommunikén i sin helhet finns som bilaga till detta meddelande samt på bolagets internetsidor www.sagafurs.com.Coronapandemins negativa inverkan på Saga Furs Oyj:s förmedlingsförsäljning minskade under den andra halvårsperioden – räkenskapsperiodens resultat dock klart förlustbringandeUnder räkenskapsperioden 1.11.2019–31.10.2020 minskade värdet på Saga Furs Oyj:s förmedlingsförsäljning med 47 procent jämfört med föregående räkenskapsperiod och var 157 miljoner euro (2018/2019: 297 milj. euro).Antalet förmedlade skinn och prisnivån...
Aditxt Secures $5 Million Financing to Scale AditxtScore™ Operational Capacity
Written by Customer Service on . Posted in Public Companies.
Balance Sheet Further Strengthened by Receipt of Additional $3.3 Million from Exercise of Existing WarrantsMountain View, CA, Jan. 26, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Aditx Therapeutics, Inc. (Aditxt) (the “Company”) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, today announced that it has entered into a securities purchase agreement in connection with a financing with an institutional investor (the “Investor”). Upon the closing of the financing, after taking into account an original issue discount and other transaction fees, the Company expects to receive approximately $4.5 million of net cash proceeds, which will be used to launch and scale the Company’s AditxtScore™ immune monitoring...
Atico Continues to Expand Footprint with High Grade Copper-Gold Intercepts Reporting 34.1g/t Au, 112 g/t Ag and 11% Cu over 3 meters at La Plata Project, Ecuador
Written by Customer Service on . Posted in Public Companies.
VANCOUVER, British Columbia, Jan. 26, 2021 (GLOBE NEWSWIRE) — Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTC: ATCMF) is pleased to report on the last results of its 2020 drilling program at the La Plata precious metals-rich volcanogenic massive sulphide (“VMS”) project in Ecuador. These results continue to report very encouraging intercepts of volcanic massive sulfides while the new 2021 drill campaign begins in Ecuador.La Plata Drilling Highlights Include:True widths are dependent on uncertainties in the local strike and dip of the mineralization and are estimated to be between 76% and 83% of the drill intercept.Drill holes CMLP-20-146 & CMLP-20-150 were both drilled outside of the existing resource polygon. Drilling was performed to test the “Guatuza extension” of the North Block as it shows continuity...
Reporting of granting of Tryg shares to Morten Hübbe (CEO) and Lars Bonde (COO)
Written by Customer Service on . Posted in Public Companies.
Group CEO Morten Hübbe has been granted 15,349 Tryg shares for a total amount of DKK 3,155,754 and Group COO Lars Bonde has been granted 7,481 Tryg shares for a total amount of DKK 1,538,094 related to the matching shares programme from 2017.Attachment2021.01.26 Transaction statement, Morten Hübbe and Lars Bonde
Indberetning af Morten Hübbe (CEO) og Lars Bondes (COO) tildeling af Tryg-aktier
Written by Customer Service on . Posted in Public Companies.
Koncernchef Morten Hübbe har fået tildelt 15.349 Tryg-aktier til en samlet værdi på 3.155.754 DKK og koncerndirektør Lars Bonde har fået tildelt 7.481 Tryg-aktier til en samlet værdi på 1.538.094 DKK i henhold til matching shares-programmet fra 2017.For yderligere detaljer, se vedhæftning.Vedhæftet fil2021.01.26 Handelsindberetning, Morten Hübbe og Lars Bonde
Victory Square Technologies Portfolio Company, Immersive Tech, Hires Former Senior Executive of the ‘The VOID’, Steven Dooner to lead UNCONTAINED Franchise Development
Written by Customer Service on . Posted in Public Companies.
“Steven Dooner is an exceptional executive…with experience spanning over 40-years, from the inception of Chuck E. Cheese franchise scale in the mid 70’s to senior positions launching many of Disney’s LBE initiatives including a $1.5B Tokyo Disney park expansion, he is a literal Guru in the industry and we couldn’t be more thrilled to have him on our team.” – Immersive Tech’s CEO, Tim BieberVANCOUVER, British Columbia, Jan. 26, 2021 (GLOBE NEWSWIRE) — Victory Square Technologies Inc. (“VST”) (CSE:VST) (OTC:VSQTF) (FWB:6F6), a company that provides investors access to a diverse portfolio of companies in key sectors, including digital health, gaming, blockchain, AR/VR, cybersecurity, and cloud computing, is pleased to announce that its portfolio company Fantasy 360 Technologies Inc. DBA Immersive Tech (“Company”)...
Bioanalytical Systems, Inc., to Report First Quarter Fiscal 2021 Financial Results and Host Conference Call on Tuesday, February 9, 2021
Written by Customer Service on . Posted in Public Companies.
WEST LAFAYETTE, Ind., Jan. 26, 2021 (GLOBE NEWSWIRE) — Bioanalytical Systems, Inc. (NASDAQ:BASI) (the “Company”, “We”, “Our” or “Inotiv”), doing business as Inotiv, a leading provider of nonclinical and analytical contract research services, today announced that the Company will issue its financial results press release for the fiscal 2021 first quarter ended December 31, 2020, on Tuesday, February 9, 2021, after the close of the stock market, and host a conference call the same day at 4:30 p.m. Eastern Time to discuss the results.Interested parties may participate in the call by dialing:(877) 407-9753 (Domestic)(201) 493-6739 (International)The live conference call webcast will be accessible in the Investors section of the Company’s website, and directly via the following link:https://78449.themediaframe.com/dataconf/productusers/bas2/mediaframe/43273/indexl.htmlFor...
Everi Announces Selected Preliminary Fourth Quarter 2020 Results in Connection With Opportunity to Reprice a Portion of Its Outstanding Debt
Written by Customer Service on . Posted in Public Companies.
LAS VEGAS, Jan. 26, 2021 (GLOBE NEWSWIRE) — Everi Holdings Inc. (NYSE: EVRI) (“Everi” or the “Company”), a premier provider of land-based and digital casino gaming products, financial technology and player loyalty solutions, today announced selected preliminary financial results for the fourth quarter and full year ended December 31, 2020, in connection with an opportunity to take advantage of favorable market conditions to lower its cost of debt by repricing $735.5 million of its First Lien Term Loan due 2024. While the expected results demonstrate sequential improvement, the preliminary 2020 fourth quarter results reflect continued impact from the COVID-19 pandemic and related casino closures.The Company expects 2020 fourth quarter consolidated revenues to be in a range of approximately $117 million to $121 million reflecting...
Simmons First National Corporation Reports 2020 Earnings
Written by Customer Service on . Posted in Earnings Releases And Operating Results.
PINE BLUFF, Ark., Jan. 26, 2021 (GLOBE NEWSWIRE) — Simmons First National Corporation (NASDAQ: SFNC) (the “Company” or “Simmons”), parent company of Simmons Bank, today announced net income of $254.9 million for the year ended December 31, 2020, compared to $237.8 million for 2019, an increase of $17.0 million, or 7.2%. Diluted earnings per share were $2.31 for 2020, a decrease of $0.10 or 4.2%, compared to the prior year. Included in the 2020 results were $9.4 million in net after-tax merger-related, early retirement program and net branch right-sizing costs and the gains on the sales of branches in Texas and Colorado. Excluding the impact of these items, core earnings were $264.3 million for the year ended December 31, 2020, compared to $269.6 million for 2019, a decrease of $5.3 million, or 2.0%. Core diluted earnings per share...
BridgeBio Pharma, Inc. Announces Completion of Merger with Eidos Therapeutics, Inc.
Written by Customer Service on . Posted in Mergers And Acquisitions.
PALO ALTO, Calif., Jan. 26, 2021 (GLOBE NEWSWIRE) — BridgeBio Pharma, Inc. (“BridgeBio”) (Nasdaq: BBIO) today announced that it has completed its acquisition of all of the outstanding shares of Eidos Therapeutics, Inc. (“Eidos”) (formerly Nasdaq: EIDX) common stock that BridgeBio did not already own. The transaction was overwhelmingly approved by BridgeBio and Eidos stockholders. The merger reunites the teams at BridgeBio and Eidos and allows BridgeBio to deploy its full clinical and commercial infrastructure to support the development and global commercialization plans underway for Eidos’ acoramidis, a potential best-in-class therapy for patients with transthyretin (TTR) amyloidosis (ATTR). BridgeBio’s mission is to discover, create, test and deliver transformative medicines to treat patients who suffer from genetic diseases and...